This month’s “Company Spotlight” takes a closer look at Othram Inc which applies the power of modern sequencing technology and genomics to forensics. David Mittelman, Chief Executive Officer of Othram, discussed with us...read more
Latest blogs
Immunotherapy and the Basis of Neoantigen Biology: Part II Cancer Immunotherapies
Last month’s Immunotherapy and the Basis of Neonatigen Biology blog post focused on neoantigens along with some facets of immunology and cancer that are interrelated. We described in detail how neoantigens and other...read more
BioIT 2019: The New “Official” Future Involves Data Sharing, Artificial Intelligence, Open Source, and More
The 18th installment of Boston’s Bio-IT World Conference was attended by over 3,400 participants and featured more than 185 exhibiting companies, both established and startups. The conference program kicked off with a...read more
Sentieon Solves Complex Mathematical Problems – Applied to DNA Sequence Secondary Data Analysis – by Enhancing them With Extreme Accuracy and Efficiency
This month’s “Company Spotlight” provides a closer look at Sentieon, a developer and supplier of a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast...read more
Blueprint Genetics Aims to Automate and Improve Clinical Interpretation Processes with Software That Will Change the Industry
This month’s “Company Spotlight” takes a closer look at Blueprint Genetics, a rare disease diagnostics company on a mission to deliver the highest quality standards for genetic diagnostics. Tero-Pekka Alastalo, Chief...read more
JP Morgan 2019 – Drug pricing, drug development, immunotherapy, cancer moonshot, cell/gene-therapy, …
As we all know the JP Morgan Healthcare conference is an invitation-only conference. For this reason, I have summarized various announcements for the purpose of this review. As we have witnessed in the past, exciting...read more
2018: Population Studies, Immunotherapy, CRISPR, Genomic Medicine,…2019
2018 was full of significant developments in the life sciences, precision medicine, genetics, and genomics sector. Highlights and notable news included various technological advancements, new clinical applications of...read more
